Stocks › MDXG
MiMedx MDXG
US equityMarket cap rank #3671
$3.31 +$0.03 (+0.91%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.31 0.00%
Open$3.25
Prev close$3.28
Day range$3.23 – $3.39
Volume1.11M
Market cap$483.01M
P/E (TTM)–
Dividend yield–
MDXG Stock News
Headlines matching MiMedx or the MDXG ticker, most recent first.
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $8
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $5 Negative
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Raises Target Price to $7 Positive
- A Quick Look at Today's Ratings for MiMedx(MDXG.US), With a Forecast Between $5 to $8
- Citizens JMP Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $6 Negative
- Citizens JMP Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $7 Negative
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $7
- Northland Securities Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $6 Negative
- Mizuho Securities Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilon Health (AGL), MiMedx Group (MDXG) and Park Dental Partners, Inc. (PARK)
- Lake Street Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Northland Securities Maintains MiMedx(MDXG.US) With Buy Rating, Maintains Target Price $10
- Citizens JMP Initiates MiMedx(MDXG.US) With Buy Rating, Announces Target Price $10
- Mizuho Securities Maintains MiMedx(MDXG.US) With Buy Rating, Cuts Target Price to $7 Negative
- Craig-Hallum Maintains MiMedx(MDXG.US) With Buy Rating, Announces Target Price $7
No comments yet — be the first to weigh in on MDXG.
Sign in to join the discussion.